Back
Meta Platforms, Inc. Vs. Rhythm Pharmaceuticals, Inc. Industry Stock Comparison
Sell
45
META
Meta Platforms, Inc.
Last Price:
$644.30
Seasonality Move:
9.96%
Buy
75
RYTM
Rhythm Pharmaceuticals, Inc.
Last Price:
$113.50
Seasonality Move:
-9.01%
Sell
45
Meta Platforms, Inc. (META)
is a Sell
Is Meta Platforms, Inc. a Buy, Sell or Hold?
-
The current Meta Platforms, Inc. [META] share price is $644.23. The Score for META is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
META is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
75
Rhythm Pharmaceuticals, Inc. (RYTM)
is a Buy
Is Rhythm Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Rhythm Pharmaceuticals, Inc. [RYTM] share price is $113.56. The Score for RYTM is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
-
RYTM is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
META Stock Price Chart
What is Meta Platforms, Inc.'s stock price today?
-
The Meta Platforms, Inc. share price today is $644.23Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and META is experiencing selling pressure, which indicates risk of future bearish movement.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals, Inc.'s stock price today?
-
The Rhythm Pharmaceuticals, Inc. share price today is $113.56Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing slight selling pressure.
META Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.48 | Sell |
| Relative Strength Index (14 RSI): | 48.13 | Sell |
| Chaikin Money Flow: | -11840508 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (605.41 - 654.31) | Buy |
| Bollinger Bands (100): | (652.61 - 767.63) | Sell |
RYTM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.67 | Buy |
| Relative Strength Index (14 RSI): | 59.45 | Buy |
| Chaikin Money Flow: | -357754 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (98.81 - 108.61) | Buy |
| Bollinger Bands (100): | (93.91 - 107.83) | Buy |
META Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 655.67 | Sell |
| 20-day SMA: | 632.35 | Buy |
| 50-day SMA: | 667.46 | Sell |
| 200-day SMA: | 671.11 | Sell |
| 8-day EMA: | 650.51 | Sell |
| 20-day EMA: | 646 | Sell |
| 50-day EMA: | 664.34 | Sell |
| 200-day EMA: | 668.05 | Sell |
RYTM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 107.1 | Buy |
| 20-day SMA: | 105.06 | Buy |
| 50-day SMA: | 105.14 | Buy |
| 200-day SMA: | 81.74 | Buy |
| 8-day EMA: | 108.55 | Buy |
| 20-day EMA: | 106.16 | Buy |
| 50-day EMA: | 103.93 | Buy |
| 200-day EMA: | 86.65 | Buy |
Meta Platforms, Inc. Earnings Growth & META Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.65 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.30 per share, and an increase next year of $5.14 per share.
Rhythm Pharmaceuticals, Inc. Earnings Growth & RYTM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.02 per share, and an increase next year of $0.56 per share.
Meta Platforms, Inc. Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Rhythm Pharmaceuticals, Inc. Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||